Nicolas Scheuer - Publications, H-index & Citations

Nicolas Scheuer

Erasmus University Rotterdam

8H指数

37论文数

417被引数

收录论文 13

发表时间

Estimating per-protocol effects in external comparator analyses using real-world data 使用真实世界数据在外部对照分析中估计依从性分析效应

Journal of Comparative Effectiveness Research

IF2.5

2025-10-01

OAAI

Gupta, Alind; Merinopoulou, Evie; Duffield, Stephen J.; Gomes, Manuel; Kent, Seamus; Scheuer, Nicolas; Machnicki, Gerardo; Sanglier, Thibaut

Quantitative Bias Analysis for Single-Arm Trials With External Control Arms 单臂试验的外部对照臂定量偏倚分析

JAMA NETWORK OPEN

IF9.7

2025-03-26

OAAI

Gupta, Alind; Hsu, Grace; Kent, Seamus; Duffield, Stephen J.; Merinopoulou, Evie; Lockhart, Alexandre; Arora, Paul; Ray, Joshua; Wilkinson, Samantha; Scheuer, Nicolas; Ramagopalan, Sreeram V.; Groenwold, Rolf H. H.; Popat, Sanjay; Hernan, Miguel A.

Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer 用真实世界的合成控制臂应对挑战，以证明普拉斯替尼在非小细胞肺癌中的相对有效性

NATURE COMMUNICATIONS

IF15.7

2022-06-17

OAAI

Popat, Sanjay; Liu, Stephen V.; Scheuer, Nicolas; Hsu, Grace G.; Lockhart, Alexandre; Ramagopalan, Sreeram V.; Griesinger, Frank; Subbiah, Vivek

Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer 吸烟史与接受派姆单抗一线治疗的晚期非小细胞肺癌患者总生存期的关系

JAMA NETWORK OPEN

IF9.7

2022-05-25

OAAI

Popat, Sanjay; Liu, Stephen V.; Scheuer, Nicolas; Gupta, Alind; Hsu, Grace G.; Ramagopalan, Sreeram V.; Griesinger, Frank; Subbiah, Vivek

Assessment of Alectinib vs Ceritinib in ALK-Positive Non-Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data

JAMA NETWORK OPEN

IF9.7

2021-10-07

OAAI

Wilkinson, Samantha; Gupta, Alind; Scheuer, Nicolas; Mackay, Eric; Arora, Paul; Thorlund, Kristian; Wasiak, Radek; Ray, Joshua; Ramagopalan, Sreeram; Subbiah, Vivek

SECUKINUMAB SIGNIFICANTLY REDUCES PSORIASIS-RELATED WORK IMPAIRMENT AND INDIRECT COSTS COMPARED TO USTEKINUMAB AND ETANERCEPT IN MOROCCO

VALUE IN HEALTH

IF6

2018-10-01

OAAI

Kooli, A.; Graham, C.; Scheuer, N.; Gilloteau, I; Miles, L.; Sherif, B.; McBride, D.

SECUKINUMAB SIGNIFICANTLY REDUCES PSORIASIS-RELATED WORK IMPAIRMENT AND INDIRECT COSTS COMPARED TO USTEKINUMAB AND ETANERCEPT IN TUNISIA

VALUE IN HEALTH

IF6

2018-10-01

OAAI

Kooli, A.; Graham, C.; Scheuer, N.; Gilloteau, I; Miles, L.; Sherif, B.; McBride, D.

PIK3CA mutation status in tumor tissue and ctDNA as a biomarker for PFS in patients with HR+, HER2-ABC treated with buparlisib or placebo plus fulvestrant: results from the BELLE-2 and BELLE-3 randomized studies

MOLECULAR CANCER THERAPEUTICS

IF5.5

2018-01-01

PREAI

Baselga, Jose; Sellami, Dalila; El-Hashimy, Mona; Dharan, Bharani; Wang, Amanda; Scheuer, Nicolas; Sankaran, Banu; Di Leo, Angelo

Biomarker analysis in HR+, HER2-, locally advanced, or metastatic breast cancer patients treated with buparlisib: results from BELLE-3

MOLECULAR CANCER THERAPEUTICS

IF5.5

2018-01-01

PREAI

Solovieff, Nadia; Wang, Ying A.; Sankaran, Banu; Scheuer, Nicolas; El-Hashimy, Mona; Weber, Denis; Sellami, Dalila; Di Leo, Angelo

Efficacy results based on PIK3CA status in BELLE-3: A Phase 3 study of buparlisib (BKM120) + fulvestrant in postmenopausal women with aromatase inhibitor-treated, HR+/HER2-ABC after progression on an mTOR inhibitor

CANCER RESEARCH

IF16.6

2017-07-01

PREAI

O'Regan, Ruth; Arteaga, Carlos L.; Bachelot, Thomas; Ciruelos, Eva; Lonning, Per E.; Sankaran, Banu; Wang, Ying A.; Scheuer, Nicolas; Sellami, Dalila; Hirawat, Samit; Di Leo, Angelo

Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort

BMC PUBLIC HEALTH

IF3.6

2010-10-22

OAAI

Teutsch, Suzy; Luciani, Fabio; Scheuer, Nicolas; McCredie, Luke; Hosseiny, Parastu; Rawlinson, William; Kaldor, John; Dore, Gregory J.; Dolan, Kate; Ffrench, Rosemary; Lloyd, Andrew; Haber, Paul; Levy, Michael

Incidence and risk for acute hepatitis C infection during imprisonment in Australia

EUROPEAN JOURNAL OF EPIDEMIOLOGY

IF5.9

2010-01-19

PREAI

Dolan, Kate; Teutsch, Suzy; Scheuer, Nicolas; Levy, Michael; Rawlinson, William; Kaldor, John; Lloyd, Andrew; Haber, Paul

Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation

MEDICAL JOURNAL OF AUSTRALIA

IF8.5

2009-08-03

PREAI

Degenhardt, Louisa; Larance, Briony K.; Bell, James R.; Winstock, Adam R.; Lintzeris, Nicholas; Ali, Robert L.; Scheuer, Nicolas; Mattick, Richard P.

研究方向